November 8, 2019

Relevium Executes LOI to Acquire Montreal Biopharma Contract Manufacturing Company

Relevium Technologies Inc. announces it has executed an LOI to acquire a biopharma contract manufacturing company.
November 7, 2019

Relevium Technologies Appoints Mark Billings as Chief Financial Officer

Relevium Technologies is pleased to announce the appointment of Mark Billings, CFA as Chief Financial Officer for both Relevium and...
October 30, 2019

Relevium’s Subsidiary BGX E-Health Secures One Million Dollar Export Contract for the Middle East

Relevium Technologies Inc. is pleased to announce that its wholly owned subsidiary, BGX E-Health LLC, has received a purchase order.
October 29, 2019

Relevium Enters Into LOI to Unlock Value of Wholly Owned Subsidiary BGX E-Health LLC and Announces Conference Call With CEO

Relevium is pleased to announce the Company received a letter of intent to roll its interest in its subsidiary BGX...
October 17, 2019

Relevium Acquires 100 Percent of Late Stage Processing and Medical Sales Applicant Weedsense

Relevium Technologies Inc. is pleased to announce its subsidiary, Biocannabix, has executed an Agreement to acquire 100 percent of the...
October 9, 2019

Relevium Enters Into Manufacturing Agreement With Bio V Pharma and Registers 400 NPN Numbers With Health Canada

Relevium is pleased to announce today that it has registered 400 Natural Product Numbers with Health Canada through its main...
September 23, 2019

Relevium CEO: We’re Positioned to Lead Latin America’s Cannabis Industry

Relevium CEO Aurelio Useche joined the Investing News Network to provide an overview of the company and an update on...